We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Research team leader Professor Klaus Gerwert and study lead author Dr. Grischa Gerwert in a betaSENSE laboratory (Photo courtesy of Dennis Yenmez/Stadt Bochum)

Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s

A novel immuno-infrared blood test detects misfolded protein biomarkers for Alzheimer’s and Parkinson’s disease. More...
27 May 2026
Image: The study represents a major pediatric oncology breakthrough, offering a potential roadmap for personalizing treatment in difficult-to-treat childhood cancers (image credit: Adobe Stock)

Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers

A measure of tumor chromosome abnormalities predicts benefit from irinotecan plus a PARP inhibitor in relapsed pediatric cancers. More...
27 May 2026
Image: Artera’s multi-modal AI platform analyzes digital pathology and clinical data to support personalized cancer management (photo courtesy of Artera)

Artera to Highlight AI-Based Cancer Risk Stratification at ASCO 2026

Artera’s multimodal artificial intelligence (MMAI) platform will be featured in multiple presentations at the ASCO 2026 Annual Meeting More...
27 May 2026
Image: The FDA The designation recognizes the test’s potential to aid Alzheimer’s diagnosis through a simple, non-invasive urine sample (Image credit: Shutterstock)

Urine-Based Alzheimer’s Test Receives FDA Breakthrough Device Designation

The TOBY Test for Alzheimer’s Disease has received FDA Breakthrough Device Designation as a non-invasive urine-based aid for Alzheimer’s diagnosis. More...
27 May 2026
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

An AI approach that analyzes bone marrow slides could help guide treatment and transplant decisions in myeloma. More...
26 May 2026
Image: Using Diasorin’s Flex Software, laboratories can tailor target selection to seasonality, clinical presentation, current clinical guidelines, recent patient travel history, or immune status (Photo courtesy of Diasorin)

FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets

Diasorin has received U.S. FDA 510(k) clearance for the LIAISON PLEX Gastrointestinal Flex Assay that detects 24 gastrointestinal pathogen targets. More...
26 May 2026
Image: Primary central nervous system lymphoma (PCNSL) is a rare malignancy of the brain, spinal cord, and eyes that is often diagnosed late and associated with poor outcomes (Photo courtesy of Tdvorak / Wikimedia Commons / CC BY-SA 3.0)

Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma

A new study identifies a biomarker that could support earlier diagnosis of rare, aggressive brain and eye cancers. More...
26 May 2026
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Manual Pipetting Aid
Pipette Controllers macro
ADLM